Riskpilot← Back to searchSign inGet full accessMilli1 Scandinavia AB
ABActiveOrg 5591631758Trängkårsvägen 83Manufacture of homogenised food preparations and dietetic food · NACE 1086Est. 20180 employees
Revenue 2024
SEK 148K
-24% vs 2023
EBITDA margin
-98.5%
-574% vs 2023
Equity ratio
-47.8%
Financial strength
Net profit 2024
SEK -205K
-860% vs 2023
| Revenue | SEK 148K | -24% |
| EBITDA | SEK -145K | -574% |
| Net profit | SEK -205K | -860% |
| Total assets | SEK 366K | +160% |
| Equity | SEK -175K | -683% |
| Employees | 0 | — |
Legal name
Milli1 Scandinavia AB
Org number
5591631758
Legal form
Aktiebolag
NACE code
1086 · Manufacture of homogenised food preparations and dietetic food
Founded
21 juni 2018
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firmanbeträffande löpande förvaltningsåtgärder
Company purpose
Föremålet för bolagets verksamhet är tillverkning och försäljning av kosttillskottspreparat, äga och förvalta patent jämte värdepapper och därmed förenlig verksamhet.
Address
Trängkårsvägen 83
Email
thomas.lenz@milmed.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 363 | 102 | 0 | 194 | 148 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 13 | 2 | −39 | −22 | −145 |
| Depreciation & amort. | −0 | −0 | −0 | — | — |
| EBIT | 13 | 2 | −39 | −22 | −145 |
| Net financials | −2 | — | 39 | 0 | −59 |
| Profit before tax | 11 | 3 | 0 | −21 | −205 |
| Tax | −3 | −1 | −0 | — | — |
| Net profit | 8 | 2 | 0 | −21 | −205 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 219 | 197 | 189 | 141 | 366 |
| Equity | 49 | 51 | 51 | 30 | −175 |
| Long-term debt | 0 | 0 | 0 | — | 346 |
| Short-term debt | 170 | 146 | 137 | 111 | 195 |
| Total debt | 170 | 146 | 137 | 111 | 541 |
EBITDA margin
-98.5%
This company
15.8%
Market median
-723% vs market
20202024
Equity ratio
-47.8%
This company
38.2%
Market median
-225% vs market
20202024
Return on equity
-20492700.0%
This company
18.4%
Market median
-111373470% vs market
20202024
Net profit margin
-138.7%
This company
8.1%
Market median
-1812% vs market
20202024
Asset turnover
0.40×
This company
1.12×
Market median
-64% vs market
20202024
Debt / equity
3.09×
This company
0.62×
Market median
-398% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
TN Audit | Audit | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2020 | |
| Board of Directors | 2020 | |
| Chairman | 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Milmed Unico AB
Milli1 Scandinavia AB Board members of Milli1 Scandinavia AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tomas Nöjd | Audit | 0 companies |
| Johan Axel Fryksenius | Board of Directors | 0 companies |
| Håkan Arne Östgren | Board of Directors | 0 companies |
| Tomas Axel Henrik Lenz | Chairman | 0 companies |